新光药业：和丰投资持股比例下降至15%以下

Group 1 - The core point of the article is that Shengzhou Hefeng Investment Co., Ltd. has reduced its stake in New Light Pharmaceutical by selling 10.7001 million shares, which represents 6.6876% of the company's total share capital [1] - Following this transaction, the holding percentage of Shengzhou Hefeng Investment has decreased from 21.6875% to 14.9999% [1] - This change in equity ownership has triggered thresholds of 1% and 5% [1]